Polycystic Kidney Disease Research Participation

Polycystic Kidney Disease Data Repository

Recruiting Observational Study
Polycystic Kidney Disease
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
The Rogosin Institute · Other
Who this trial is looking for

This trial is looking for adults with a diagnosis of autosomal dominant polycystic kidney disease (ADPKD). Participants will help researchers understand the disease and its complications over time.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 18 years old or older
  • I have been diagnosed with autosomal dominant polycystic kidney disease

You may not be able to join if

  • I am unable to provide informed consent

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
Autosomal dominant polycystic kidney disease (PKD) is the most common inherited kidney disease, affecting more than 400,000 people in the U.S. and 5 million people worldwide. PKD is the 4th most common cause of kidney failure requiring dialysis and/or transplantation. Over half of all PKD patients develop kidney failure by age 60 years, although age of onset of kidney disease varies widely, even a…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Any person, age 18 or older, with previously diagnosed ADPKD is eligible to participate. Exclusion Criteria: * Inability to provide informed consent.
Contacts

Jon Blumenfeld, MD

212-746-1553

jdblume@nyp.org

CONTACT